ABU DHABI BECOME THE FIRST TO RECEIVE NEW MEDICATION TO PROTECT IMMUNOCOMPROMISED AGAINST COVID 19

  • 03/11/2021

Abu Dhabi: Abu Dhabi has turned into the first to get another medicine to secure immunocompromised patients against Covid-19, supporting endeavors to ensure all individuals from the local area in UAE's capital. 


Branch of Health – Abu Dhabi, in a joint effort with Rafed, the UAE's essential gathering buying association (GPO) for the inventory network of fundamental clinical gear, reported the marking of the obtainment of AstraZeneca's AZD7442 into the nearby market, as per an assertion gave on Wednesday. 

The new and creative drug is explicitly intended to forestall serious disease and passing in non-inoculated high-hazard patients. 

This understanding comes in accordance with the country's endeavors to battle Covid-19, making the UAE among the main gathering of nations to get the neutralizer prescription for immunocompromised patients. 

Abu Dhabi has driven a compelling human-fixated reaction dependent on joint effort with driving nearby and global drug organizations since the beginning of the Covid-19 pandemic. For AZD7442, the Department of Health has dealt with setting up a consistent production network process by means of Rafed, which will work with the obtainment, stockpiling, and dissemination of the AstraZeneca medicine through the Rafed Distribution Center, the district's biggest office well versed in cool stockpiling.

Related News